{
  "Variants Include": [
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.89C>T",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "C",
            "alt": "T",
            "position": "89"
          },
          "Protein Change": {
            "ref": "P",
            "alt": "L",
            "position": "30"
          },
          "Description in input context": "A30P"
        }
      ]
    },
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.159G>T",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "G",
            "alt": "T",
            "position": "159"
          },
          "Protein Change": {
            "ref": "A",
            "alt": "V",
            "position": "53"
          },
          "Description in input context": "A53T"
        }
      ]
    },
    {
      "Gene": "SNCA",
      "variants": [
        {
          "HGVS": "NM_000345.4:c.89C>T,c.159G>T",
          "cDNA Change": {
            "transcript": "NM_000345.4",
            "ref": "CCGG",
            "alt": "TTAG",
            "position": "89,159"
          },
          "Protein Change": {
            "ref": "PPAA",
            "alt": "LLVV",
            "position": "30,53"
          },
          "Description in input context": "A30P/A53T"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease",
    "MONDO": "MONDO:0005634"
  },
  "Experiment Method": [
    {
      "Assay Method": "Ultracentrifugation",
      "Material used": {
        "Material Source": "Lipid vesicles",
        "Material Name": "phospholipid vesicles",
        "Description": "Phospholipid vesicles were prepared using a standard protocol."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_000345.4:c.89C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The A30P variant showed a decrease in binding affinity to lipid vesicles."
        },
        {
          "Variant": "NM_000345.4:c.159G>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "The A53T variant showed a decrease in binding affinity to lipid vesicles."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three biological replicates were performed for each variant."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": ""
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": ""
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": ""
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": ""
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Binding affinity greater than 80%.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Binding affinity less than 50%.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}